MDGL Next Earnings Date Notes

— Madrigal Pharmaceuticals (MDGL) is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for fatty liver, cardiovascular, and metabolic diseases. Its lead asset, resmetirom, is a once-daily oral liver-directed thyroid hormone receptor-b2 agonist designed to address nonalcoholic steatohepatitis (NASH), now referred to as metabolic dysfunction-associated steatohepatitis (MASH). With resmetirom having recently secured FDA approval for MASH with liver fibrosis, the company's prospects hinge not only on successful commercial launch execution but also on expanding its label for broader populations. For investors tracking MDGL, it's critical to monitor prescription & sales ramp of resmetirom, payer coverage & reimbursement progress, patient uptake metrics, and updates on post-marketing clinical programs. Additionally, keep an eye on cash runway, quarterly operating expenses, and the company's ability to achieve positive cash flow as launch matures. Pipeline updates and regulatory developments, especially in the context of global expansion or new indications, are also highly relevant. These metrics collectively provide insight into MDGL's growth trajectory & long-term sustainability ahead of and during their next earnings call. The next projected earnings date for MDGL is 8/4/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

MDGL Next Earnings Date FAQ

On this page we presented the MDGL Next Earnings Date information for Madrigal Pharmaceuticals along with recent past earnings dates. For Q1 of 2026, MDGL reported earnings of -3.250/share, with the earnings report taking place on 5/6/2026. For Q4 of 2025, MDGL reported earnings of -2.570/share, with the earnings report taking place on 2/19/2026. For Q3 of 2025, MDGL reported earnings of -5.080/share, with the earnings report taking place on 11/4/2025. For Q2 of 2025, MDGL reported earnings of -1.900/share, with the earnings report taking place on 8/5/2025. For Q1 of 2025, MDGL reported earnings of -3.320/share, with the earnings report taking place on 5/1/2025. Based on these past earnings dates, the projected next earnings date for MDGL is 8/4/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Madrigal Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Madrigal Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Madrigal Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next MDGL earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up MDGL's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the MDGL next earnings date.